Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Bard

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Pharmacogenomics|October 17, 2018
RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptomsPaul J Isackson, Jianxin Wang, Mohammad Zia, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Synthesis and SAR of bis-statine based peptides as BACE 1 inhibitorsBaihua Hu, Kristi Yi Fan, Kristie Bridges, et al.
Frontiers in Immunology|December 16, 2021
Transcriptomic and Single-Cell Analysis Reveals Regulatory Networks and Cellular Heterogeneity in Mouse Primary Sjögren's Syndrome Salivary GlandsErich Horeth, Akinsola Oyelakin, Eun-Ah Christine Song, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2025
In Vivo PET Imaging of [<sup>18</sup>F]CHDI-385, a Radioligand for Mutant Huntingtin Aggregates in a Mouse Model of Huntington DiseaseFranziska Zajicek, Filipe Elvas, Alan Miranda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2021
Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease PostmortemDaniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, et al.
Plos One|April 30, 2015
Global Developmental Gene Programing Involves a Nuclear Form of Fibroblast Growth Factor Receptor-1 (FGFR1)Christopher Terranova, Sridhar T Narla, Yu-Wei Lee, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 16, 2022
Validation, kinetic modeling, and test-retest reproducibility of [<sup>18</sup>F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in miceDaniele Bertoglio, Franziska Zajicek, Stef De Lombaerde, et al.
Database : the Journal of Biological Databases and Curation|July 15, 2010
Mouse Resource Browser--a database of mouse databasesMichael Zouberakis, Christina Chandras, Morris Swertz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 27, 2024
Preclinical evaluation of the novel [<sup>18</sup>F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's diseaseFranziska Zajicek, Jeroen Verhaeghe, Stef De Lombaerde, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2021
Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's diseaseDaniele Bertoglio, Jeroen Verhaeghe, Alan Miranda, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Pharmacogenomics|October 17, 2018
RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptomsPaul J Isackson, Jianxin Wang, Mohammad Zia, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Synthesis and SAR of bis-statine based peptides as BACE 1 inhibitorsBaihua Hu, Kristi Yi Fan, Kristie Bridges, et al.
Frontiers in Immunology|December 16, 2021
Transcriptomic and Single-Cell Analysis Reveals Regulatory Networks and Cellular Heterogeneity in Mouse Primary Sjögren's Syndrome Salivary GlandsErich Horeth, Akinsola Oyelakin, Eun-Ah Christine Song, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2025
In Vivo PET Imaging of [<sup>18</sup>F]CHDI-385, a Radioligand for Mutant Huntingtin Aggregates in a Mouse Model of Huntington DiseaseFranziska Zajicek, Filipe Elvas, Alan Miranda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2021
Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease PostmortemDaniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, et al.
Plos One|April 30, 2015
Global Developmental Gene Programing Involves a Nuclear Form of Fibroblast Growth Factor Receptor-1 (FGFR1)Christopher Terranova, Sridhar T Narla, Yu-Wei Lee, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 16, 2022
Validation, kinetic modeling, and test-retest reproducibility of [<sup>18</sup>F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in miceDaniele Bertoglio, Franziska Zajicek, Stef De Lombaerde, et al.
Database : the Journal of Biological Databases and Curation|July 15, 2010
Mouse Resource Browser--a database of mouse databasesMichael Zouberakis, Christina Chandras, Morris Swertz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 27, 2024
Preclinical evaluation of the novel [<sup>18</sup>F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's diseaseFranziska Zajicek, Jeroen Verhaeghe, Stef De Lombaerde, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2021
Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's diseaseDaniele Bertoglio, Jeroen Verhaeghe, Alan Miranda, et al.
Pageof 8